Diagnosis and Differentiation of SLE and MCTD

Introduction to SLE and MCTD

The American College of Rheumatology suggests that a person with a nuclear homogeneous ANA pattern can have either SLE or MCTD, though the homogeneous pattern is more classically associated with SLE than MCTD 1, 2
The European League Against Rheumatism notes that the nuclear homogeneous pattern is primarily associated with antibodies to double-stranded DNA (dsDNA), histones, and chromatin, which are characteristic of SLE 3, 1

The presence of a homogeneous pattern does not exclude MCTD or definitively confirm SLE—the pattern alone cannot make the diagnosis, as stated by the American College of Rheumatology 1, 2
SLE most commonly presents with homogeneous or speckled patterns, with the homogeneous pattern being particularly associated with anti-dsDNA and anti-histone antibodies, according to the European League Against Rheumatism 1
MCTD classically presents with a coarse speckled pattern due to anti-U1-RNP antibodies, but patients can have multiple overlapping ANA patterns simultaneously, as noted by the American College of Rheumatology 1, 4
Anti-dsDNA antibodies are a first priority for homogeneous pattern testing, with both Crithidia luciliae immunofluorescence test (CLIFT) for high specificity and solid phase assays (ELISA/FEIA) for high sensitivity, recommended by the Autoimmunity Reviews 3, 2
Positive anti-dsDNA strongly suggests SLE over MCTD, according to the Autoimmunity Reviews 3, 4

An extractable nuclear antigen (ENA) panel must include anti-Sm antibodies, which are highly specific for SLE, and anti-U1-RNP antibodies, which are a defining feature of MCTD, as recommended by the Praxis Medical Insights 4, 5
Never rely on ANA pattern alone to make or exclude a diagnosis—the pattern guides follow-up testing but does not determine the final diagnosis, as stated by the American College of Rheumatology 1, 2
Do not assume a homogeneous pattern automatically means SLE—you must confirm with anti-dsDNA and other specific antibodies, according to the Praxis Medical Insights 2
In cases of high clinical suspicion for MCTD, test for anti-U1-RNP antibodies regardless of whether the pattern is homogeneous or speckled, recommended by the Praxis Medical Insights 2, 4

The diagnosis of SLE versus MCTD requires integration of clinical features, not just serological patterns, as noted by the Praxis Medical Insights 2, 4
Look for MCTD features such as Raynaud's phenomenon, puffy hands, myositis, esophageal dysmotility, pulmonary hypertension, and very high titer anti-U1-RNP antibodies, according to the Praxis Medical Insights 4
Look for SLE features such as malar rash, photosensitivity, oral ulcers, serositis, nephritis, cytopenias, neurological manifestations, and positive anti-dsDNA or anti-Sm, as recommended by the Autoimmunity Reviews 3, 4